Webinars

Webinars

Upcoming Webinars


June 14, 2017
Webinar Date:
REGISTER AGENDA:

Past Webinars


April 19, 2017
Webinar Date:
Join us to learn more about the Simoa HD-1 Analyzer, an ultra-sensitive fully automated immunoassay platform capable of delivering LODs at the femtogram level, multiplexing and of measuring individual proteins at concentrations 1,000 times lower than existing technologies.
April 18, 2017
Webinar Date:
Tune in as Dr. Jennifer Van Eyk discusses the need for precise protein quantification and identification for the advancement of personalized medicine
February 22, 2017
Webinar Date:
Join us to learn more about the Simoa HD-1 Analyzer, an ultra-sensitive fully automated immunoassay platform capable of delivering LODs at the femtogram level, multiplexing and of measuring individual proteins at concentrations 1,000 times lower than existing technologies.
December 15, 2016
Webinar Date:
Join us to learn more about the Simoa HD-1 Analyzer, an ultra-sensitive fully automated immunoassay platform capable of delivering LODs at the femtogram level, multiplexing and of measuring individual proteins at concentrations 1,000 times lower than existing technologies.
December 2, 2016
Webinar Date:
Hosted by Cambridge Healthtech Institute, this webinar will highlight the use of a Simoa custom assay and the commercial tau assay for different applications in mouse and human studies.
Webinar Date:
Join us to learn more about the Simoa HD-1 Analyzer, an ultra-sensitive fully automated immunoassay platform capable of delivering LODs at the femtogram level, multiplexing and of measuring individual proteins at concentrations 1,000 times lower than existing technologies.
BIO Investor Forum | October 18-19 2016
Webinar Date:
View the recording of the presentation given by CEO Kevin Hrusovsky at the BIO Investor Forum 2016
Hosted by Cambridge Healthtech Institute
Webinar Date:
Hosted by Cambridge Healthtech Institute, this webinar will describe how blood biomarkers can be used to detect CNS disorders.
Webinar Date:
Miriam Moscovitch-Lopatin, from MassGeneral Institute for Neurodegenerative Disease presented a longitudinal pre-cell biomarker study she conducted on an ultrasensitive Simoa immunoassay for quantifying BDNF levels in cerebral spinal fluid in early Huntington's disease at the inaugural Powering P
Webinar Date:
Alison Joyce from Pfizer, Inc. presented her research on the development of a sensitive homebrew Simoa assay to detect Leucine-rich repeat Kinase 2 (LRRK2) at the inaugural Powering Precision Health Summit 2016.